Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Immunotherapy and future directions in oncology

Immunotherapy and future directions in oncology Monoclonal antibody-based technologies have now been in use for decades targeting specific cancer cells to serve either as therapeutics (eg Genentech's trastuzumab, Herceptin) or invitro diagnostics (immunoassays) or to ... received prior treatment with

Roche says Tecentriq "off to a good start"

Roche says Tecentriq Strong gains for Perjeta (pertuzumab) and Kadcyla (ado-trastuzumab emtansine) reinforced a 5% increase for HER2 stalwart Herceptin (trastuzumab) to 3.4bn francs.

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The Japanese drugmaker gains exclusive commercialisation rights to nine drugs in Amgen's biosimilar pipeline, including its Humira clone and copies of Roche's anticancer drugs Avastin (bevacizumab) and Herceptin (trastuzumab).

Lilly and Boehringer combine breast cancer drugs in trial

Lilly and Boehringer combine breast cancer drugs in trial Herceptin (trastuzumab).

European pharma ‘to grow 3.2% per year by 2022’

European pharma ‘to grow 3.2% per year by 2022’ Cancer treatments are set to provide five compounds in the top 10 in 2022, although Roche's Herceptin (2015 sales of 2.117 bn to 2022 sales of 1.383 bn) ... Among these is Mylan and Biocon's MYL-1401O, whose data was shown to be comparable in efficacy

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics